Last checked at 
(Adds details)
HELSINKI, March 24 (Reuters) - Finland will resume using the
AstraZeneca vaccine against COVID-19 from Monday, but
will only give it to people aged 65 and over, the country's
Institute of Health and Welfare said on Wednesday.
Several European countries stopped administering the shot
after reports of a small number of blood disorders, but most
have begun using it again after regulators said the benefits
outweighed any risks.
"We have not detected people that have turned 65 to have an
increased risk of blood clotting so we can resume vaccinating
them," Taneli Puumalainen, chief physician at the Finnish
Institute for Health and Welfare said in a press release on
Wednesday.
The institute is still looking into two cases of blood clots
in Finland and said it needed more time to complete its
investigation, which will be finished on April 6 the earliest.
(Reporting by Gwladys Fouche, editing by Essi Lehto and Toby
Chopra)
